# DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

> **NCT03033433** · PHASE1 · COMPLETED · sponsor: **VitNovo, Inc.** · enrollment: 28 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** DCB-DM101

## Key facts

- **NCT ID:** NCT03033433
- **Lead sponsor:** VitNovo, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-12
- **Final completion:** 2018-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033433, "DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03033433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*